Hong Kong: IPO SPOTLIGHT - OVERVIEW 2025
Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far. Large scale A+H dual listings have surged this...
961 Views
Innogen (银诺医药) IPO: Fairly Valued at Best and Lack of Institutional Interests
China biotech company Innogen launches IPO in Hong Kong to raise at least $88 million, with a demanding valuation and lack of institutional...
689 Views
Innogen (银诺医药) Pre-IPO Update: Cuts in Market Forecasts
China biotech company Innogen plans to raise $100 million in Hong Kong listing with CITIC Securities and CICC as joint sponsors, with scaled down...
543 Views
Innogen (银诺医药) Pre-IPO Update: New Data Points
China-based biotech company Innogen seeks to raise $100 million through Hong Kong listing. We look at updates from the company's latest prospectus...
572 Views
CICC (3908 HK): It Is the Best of the Time
CICC is alerting a strong 1H25 profit growth, leading in the HK IPO market with a promising H-share IPO pipeline of A-share companies. The market...
548 Views